Not Just Science Fiction - How Technology Will Shape the Future of Cancer Treatments

Unlike systemically delivered immunotherapies that can produce serious side effects, ImmunoPulse IL-12 is proving to be generally well tolerated and safe across multiple treatment cycles in clinical trials. DNA-based IL-12 is administered directly into the tumor using an applicator that delivers quick electric pulses to increase the permeability of cell membranes. This produces a localized immune response and educates fighter immune cells to recognize and attack cancer throughout the body, without attacking healthy cells.